VALIDATION DATA

MEASUREMENT PROPERTIES
Limitations >=5 European languages (English)
Observations
1. RELIABILITY
A. Internal Consistency Tested
Cronbach's (Describe)

Internal consistency of the SF-12 component summary scores is generally high (Cronbach’s >0.82 and 0.75, for SF-12 PCS scale and MCS scale, respectively.

B. Reliability intraobserver or test-retest Tested
Continuous scores: intraclass
correlation coefficient (ICC)
Dichotomus: Cohen kappa (Describe)

Test–retest reliability of the SF-12 administered 2 weeks apart is adequate: r = 0.89 for PCS and r = 0.76 for MCS.

C. Reliability interobserver or Measurement error Tested
Standard error of measurement (SEM),
smallest detectable change (SDC) or
Limits of agreement (LoA) (Describe)

For both the PCS and MCS scales, changes in scores between test and retest averaged less than 1 point, and at the second administration, 85% scored within the 95% confidence interval (95% CI) of the score at the first administration.

2. VALIDITY
A. Content validity: face validity Tested
Expert opinion (relevance and
comprehensiveness) (Describe)

The SF-12 was developed using regression analysis methods to select and score 12 items from the SF-36 to reproduce the PCS and MCS scales in the general US population.

B. Construct Validity:
Structural validity
Tested
Hypotheses-testing Tested
Cross-cultural validity Tested
Brief Description

The 2-factor conceptual structure of the SF-12 (PCS and MCS) has been confirmed in several population-based and clinical studies. 

C. Criterion validity Tested
Comparison with a 'gold standard' Continuous scores:
correlations, ROC curves Dichotomus:
Sensitivity & Specificity (Describe)

The SF-12 PCS and MCS scores correlate 0.95 and 0.96 with the SF-36 PCS and MCS scores, respectively. These findings have been replicated in the general populations of 9 European countries (Denmark, France, Germany, Italy, the Netherlands, Norway, Spain, Sweden, and the UK), with very high correlations between SF-12 PCS and SF-36 PCS scores (r = 0.94–0.96) and SF-12 MCS and SF-36 MCS scores (r = 0.94–0.97). Clinical trials data from patients with osteoarthritis and rheumatoid arthritis also indicate good criterion validity of the SF-12 in rheumatology, with strong correlations between the SF-12 and SF-36 PCS scores and the SF-12 and SF-36 MCS scores (r = 0.92–0.96).